BioAtla, Inc.

BCAB

Exchange: OTC
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001826892

SEC filings (opens in a new tab)

No open-market purchases or sales by BioAtla, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.22M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding BioAtla, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of BCAB: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Q2 2024	Change
Holders	84	80	−4
Shares	25.4M	22.1M	−3.22M (−12.7%)
Value	$87.2M	$30.4M	−$56.8M (−65.1%)

New holders (26)

Institutions that held BioAtla, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to BCAB in Q2 2024
Institution	Shares	Value	% of portfolio
AQR Capital Management LLC	636,136	$871.5K	0.00%
Scion Asset Management, LLC	633,959	$868.5K	1.65%
Y-Intercept (Hong Kong) Ltd	161,871	$221.8K	0.01%
Alpine Global Management, LLC	154,417	$211.6K	0.04%
Jane Street Group, LLC	136,701	$187.3K	0.00%
Paloma Partners Management Co	97,176	$133.1K	0.01%
Centiva Capital, LP	90,400	$123.8K	0.01%
Point72 Asia (Singapore) Pte. Ltd.	72,193	$98.9K	0.02%
Squarepoint Ops LLC	70,599	$96.7K	0.00%
HRT Financial LP	62,796	$86.0K	0.00%
Verition Fund Management LLC	42,200	$57.8K	0.00%
Schonfeld Strategic Advisors LLC	33,200	$45.5K	0.00%
Qube Research & Technologies Ltd	27,220	$37.3K	0.00%
Rinkey Investments	25,310	$34.7K	0.01%
Valmark Advisers, Inc.	25,126	$34.4K	0.00%
Ground Swell Capital, LLC	24,063	$33.0K	0.03%
Mirae Asset Global ETFs Holdings Ltd.	22,778	$31.2K	0.00%
Point72 (DIFC) Ltd	17,261	$23.6K	0.00%
United Bank	13,000	$17.8K	0.00%
Catalyst Funds Management Pty Ltd	11,300	$15.5K	0.00%
Neuberger Berman Group LLC	10,846	$14.9K	0.00%
Federated Hermes, Inc.	3,726	$5.11K	0.00%
Macquarie Group Ltd	2,271	$3.11K	0.00%
SRS Capital Advisors, Inc.	1,695	$2.32K	0.00%
Redwood Wealth Management Group, LLC	500	$685	0.00%
EverSource Wealth Advisors, LLC	329	$595	0.00%

Sold out (30)

Institutions that held BioAtla, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of BCAB in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Cormorant Asset Management, LP	1,170,870	$4.03M
UBS Oconnor LLC	209,770	$721.6K
Nuveen Asset Management, LLC	177,852	$611.8K
Woodline Partners LP	133,214	$458.3K
Bank of New York Mellon Corp	122,516	$421.5K
Charles Schwab Investment Management Inc	119,549	$411.2K
Panagora Asset Management Inc	89,072	$306.4K
Chase Investment Counsel Corp	76,742	$263.0K
Manatuck Hill Partners, LLC	75,000	$258.0K
Simplex Trading, LLC	43,239	$148.0K
Pathstone Holdings, LLC	34,301	$118.0K
Kennedy Capital Management, Inc.	31,408	$108.0K
Virtu Financial LLC	30,012	$103.0K
American International Group, Inc.	21,799	$75.0K
Envestnet Asset Management Inc	21,572	$74.2K
Invesco Ltd.	20,376	$70.1K
Gsa Capital Partners LLP	17,722	$61.0K
Wells Fargo & Company	15,595	$53.6K
Voya Investment Management LLC	14,805	$50.9K
Manufacturers Life Insurance Company, The	13,402	$46.1K
Price T Rowe Associates Inc	12,791	$45.0K
SG Americas Securities, LLC	13,069	$45.0K
State of Wisconsin Investment Board	12,400	$42.7K
Belvedere Trading LLC	11,734	$40.4K
California State Teachers Retirement System	4,447	$15.3K
Legal & General Group Plc	4,239	$14.6K
Ameritas Investment Partners, Inc.	3,653	$12.6K
Amalgamated Bank	1,491	$5.00K
Zurcher Kantonalbank (Zurich Cantonalbank)	477	$1.64K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	8	$27